James Priour Zymeworks Inc. (ZYME) insider trading activity

ZYME Quotes by TradingView

James Priour is Chief Commercial Officer of Zymeworks Inc.. Currently has a direct ownership of 2,513 shares of ZYME, which is worth approximately $34,855. The most recent transaction as insider was on Jul 06, 2021, when has been sold 510 shares (Common Shares) at a price of $29.49 per share, resulting in proceeds of $15,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.51K
0% 3M change
0% 12M change
Total Value Held $34,855

James Priour Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 06 2021
BUY
Grant, award, or other acquisition
$15,040 $29.49 p/Share
510 Added 16.87%
2,513 Common Shares
Apr 13 2021
SELL
Open market or private sale
$26,534 $27.93 p/Share
950 Reduced 32.17%
2,003 Common Shares
Apr 13 2021
BUY
Exercise of conversion of derivative security
-
2,266 Added 43.42%
2,953 Common Shares
JP

James Priour

Chief Commercial Officer
Vancouver, A1

Track Institutional and Insider Activities on ZYME

Follow Zymeworks Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYME shares.

Notify only if

Insider Trading

Get notified when an Zymeworks Inc. insider buys or sells ZYME shares.

Notify only if

News

Receive news related to Zymeworks Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ZYME